InvestorsHub Logo
icon url

gestalt2

02/05/19 4:23 PM

#35198 RE: finesand #35197

just to piggyback on your response, as much as we need a greater investment community exposure, I kind of think being under the radar might have some benefits. I think that once patients are using this drug after FDA approval, word will spread fast among sales reps in BP that they are not selling as much of their drugs and will be selling far less in the near future. They will be seeing the #'s that matter - lost revenue. Ultimately we don't need a manipulated SP up or down - we need BP to buy this. To get that to happen the drug has to scare BP.
icon url

ahab333

02/06/19 1:03 AM

#35258 RE: finesand #35197

Nice of you finesand to point out about ONCS. ONCS is a little known 40M cap company that has acheived 24% success rate on patients that have failed ALL other theropy's with absolutely no, nadda, other options for life and it's a major success and like you said, the market fails yet again to realize such a major break through. I own many shares of that company and like CYDY, I have 80% of all my holdings in these 2 companies.

GLTU always and thank you for all your contributions and hard work contributing here and with your blog -

HCIT